Penbrook Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Penbrook Management's BMY Position: Q2 2026 in Review
Penbrook Management increased its Bristol-Myers Squibb (BMY) stake by 5.8% in Q2 2026, buying an estimated $21K and bringing the position to 6,615 shares worth $381K. The position accounts for 0.24% of the portfolio, ranked #75.
Penbrook Management first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Penbrook Management held 6,615 shares of Bristol-Myers Squibb worth $381K as of Q2 2026.
- Penbrook Management bought 365 Bristol-Myers Squibb shares in Q2 2026, an estimated $21K.
- Bristol-Myers Squibb made up 0.24% of Penbrook Management's portfolio in Q2 2026, its #75 holding.
- Penbrook Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Penbrook Management's 13F filing for Q2 2026, filed 23 Jul 2026.